Literature DB >> 15308844

Identification of factors that influence conscious sedation in gastrointestinal endoscopy.

Sun-Young Lee1, Hee Jung Son, Ji Min Lee, Mun Hee Bae, Jae J Kim, Seung Woon Paik, Byung Chul Yoo, Jong Chul Rhee, Seonwoo Kim.   

Abstract

Although several studies examined factors that influence conscious sedation, investigation was limited into the gender and age. The aim of this prospective study is to identify the clinical variables of successful conscious sedation during gastrointestinal endoscopy. A total of 300 subjects who underwent gastrointestinal endoscopy were enrolled in a prospective fashion. They completed a questionnaire to assess height, weight, drinking, smoking, education level, recent medication, past medical history, previous experience of conscious sedation, preprocedural anxiety, and apprehension about the procedure. Efficacy of sedation and amnesia were evaluated by the subject and the endoscopist. Amnesic and sedative effects were proportionally related with age (p<0.0001). Preprocedural anxiety level was higher in women (p=0.0062), younger subjects (p=0.035), slender subjects (p=0.041), and in those without previous experience of conscious sedation (p=0.0034). This anxiety level was also related to increased pain (p=0.0026) and alertness (p=0.0003) during the procedure. Lower dose of midazolam is needed for sedation in older subjects. Subjects with a high level of preprocedural anxiety such as women, younger subjects, slender subjects, and those without previous experience of conscious sedation should be sedated with great caution because generally, they complain of much more severe pain and alertness during the procedure. Copyright The Korean Academy of Medical Sciences

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308844      PMCID: PMC2816887          DOI: 10.3346/jkms.2004.19.4.536

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


INTRODUCTION

The aim of conscious sedation in gastrointestinal endoscopy is to promote the patient's tolerance and cooperation. Thus, the clinical end-points for sedation should aim for amnesia, anxiolysis, and cooperation rather than hypnosis (1). Although propofol provides faster onset and deeper sedation than standard benzodiazepines, clinically important benefits have not been consistently demonstrated in average-risk patients undergoing standard upper and lower gastrointestinal endoscopy (2). Besides, intravenous midazolam has been proven to give the best results in gastrointestinal endoscopy due to its safety, rapid onset, shorter duration of action, anxiolysis, and amnesia (3). In addition, opiates provide analgesia, produces synergistic sedation with midazolam, and increase amnesia and patient satisfaction (4). Therefore, gastrointestinal endoscopy is still often performed under moderate sedation with benzodiazepine and narcotics. The use of conscious sedation is widespread presently, and results in a high degree of satisfaction with the procedure by both patients and physician (3, 4). However, there is no well-defined set of practice guidelines that can be used to determine which patients can undergo successful conscious sedation in gastrointestinal endoscopy. By determining the predictive clinical variables, patients scheduled for gastrointestinal endoscopic examination will be ensured of the optimal use of sedation. In addition, the identification of clinical variables in conscious sedation would contribute to better satisfaction for both patients and endoscopists. Here, we identified the clinical variables of successful conscious sedation in the Korean population by using multivariate analysis.

MATERIALS AND METHODS

Study population

This prospective study was conducted in a single health promotion center at Samsung Medical Center, Seoul, Korea. From November 2002 to February 2003, a total of 300 adult subjects who were scheduled to undergo diagnostic gastrointestinal endoscopy for routine examination were prospectively considered. Because the intention was to sedate, those who prefered not to be sedated were excluded from the study. We also excluded those who had recently taken medications such as benzodiazepines, opioids, barbiturates, and antihistamines because these drugs influence conscious sedation (5). In addition, those who had diagnosed as psychological disease including dementia and those with severe comorbid disease greater than American Society of Anesthesiology (ASA) preoperative patient classification III were excluded from the study (6). The study protocol was approved by the Ethics Committee of Samsung Medical Center, and each study participant signed an informed consent.

Endoscopic procedure

Consistent with routine practice, subjects received lidocaine anesthetic spray in a standard fashion. In the endoscopy room, all the subjects had an intravenous access for midazolam 0.07 mg/kg and pethidine 25 mg injection to achieve conscious sedation. After the injection, subjects were monitored for oxygen saturation, heart rate, blood pressure, and respiratory rate. Each subject underwent standard diagnostic upper gastrointestinal endoscopy (GIF-XQ 240, Olympus optical Co. Ltd, Tokyo, Japan) with or without sigmoidoscopy (CF 200S, Olympus optical Co. Ltd, Tokyo, Japan). In cases with sigmoidoscopy, the subjects ingested Magcorol 250 mL (magnesium carbonate 10.75 g with anhydrous citric acid 19.5 g; Taejoon, Seoul, Korea) 12 hr before the examination. Endoscopic procedure was performed by one of the four attending endoscopists with an endoscopic assistant nurse. Sigmoidoscopy was performed immediately after upper gastrointestinal endoscopic examination.

Data collection

Data collection was completed by the subjects and the endoscopists. Because the adequacy of sedation estimated by the endoscopist does not always correlate with the subjects' own perception, we approached the subject and the endoscopist blindly to each other. Before the application of intravenous midazolam injection, subjects were required to memorize two words, airplane and apple. After the procedure, all of the subjects completed a questionnaire (Table 1-1). Previous experience of conscious sedation (in the questionnaire) included during either the intraabdominal operation or endoscopy.
Table 1-1

Data collection by the subject

The efficacy of the sedation was reported by visual analogue scale (VAS) (7). The endoscopist completed a questionnaire about the degree of cooperation (0 extremely poor-100 excellent) and sedation (0 full sedation-100 alert) during the procedure. In addition, the subjects were asked to recall two words which they have heard prior to sedation (Table 1-2). This two word test was performed a total of three times in each subject; 30 sec after midazolam injection, immediately after the procedure, and 30 min after the procedure.
Table 1-2

Data collection by the endoscopist

Statistical analyses

Statistical analyses were done using SPSS software 10.0 and a p-value less than 0.05 was considered significant. The data were reported as mean standard deviation (SD) for continuous variables and percentage with 95% confidence interval (CI) for categorical variables. Multivariate analysis was performed with 11 factors (age, gender, body mass index, drinking, smoking, education level, past experience of conscious sedation, type of procedure, total time of procedure, midazolam dose, and biopsy status) to identify clinical predictors of the main outcome (two word test, consciousness, cooperation, retching, behavioral interruption, and pain) as well as preprocedural status (anxiety and apprehension about the procedure). One significant variable (self perceived preprocedural anxiety level) was analyzed by Wilcoxon's two sample test. Spearman's correlation test was used to measure the correlation between two variables expressed as categories.

RESULTS

All 300 subjects completed a questionnaire after the procedure. There was no significant side effect such as oxygen desaturation and life-threatening cardiac arrhythmia. The distribution of subject's variables and procedural variables are summarized in Table 2.
Table 2

Characteristics of the subjects (n=300)

*Plus-minus values are means±SD.

Preprocedural status as assessed by the subject revealed that the degree of preprocedural anxiety level was higher in younger subjects (p=0.035), in slender subjects (p=0.041), in women (Wilcoxon's value=2.74, p=0.0062), and in those without previous history of conscious sedation (Wilcoxon's value=2.96, p=0.030). However, preprocedural anxiety was not related to drinking, smoking, or education level. Efficacy of the sedation achieved by the endoscopist and the subject are summarized in Table 3. Impact of sedation as assessed by the endoscopist revealed that the degree of consciousness was lower in older subjects (p<0.0001). Degree of amnesia achieved by subjects revealed that older subjects were poor in remembering the procedure (Table 4). In contrast, those who were biopsied during the procedure remembered the procedure much better (p=0.049). In addition, those who underwent sigmoidoscopy with gastroscopy (p=0.032) were relatively alert than those who underwent gastroscopy alone. Slender subjects (p=0.0495) interrupted the procedure more often because of their hyperactive and irritable behavior. Higher preprocedural anxiety level was proportionally related to increased consciousness during the procedure (Table 5). Apart from consciousness, the degree of perceived pain was higher in younger subjects (p=0.0004). Those who revealed a high preprocedural anxiety level complained of much more severe pain (Table 5).
Table 3

Efficacy of the sedation achieved by the endoscopist and the subject

NS, no statistically significant relationship.

Table 4

Analysis of the data by "age" factor (n=300)

*OR denotes odds ratio; †CI denotes confidence interval; ‡p values are for the relationship between the data and the age; §Spearman's correlation coefficient.

Table 5

Association with preprocedural anxiety level

*OR denotes odds ratio; †CI denotes confidence interval; ‡p values are for the relationship between the data and the anxiety level; §Spearman's correlation coefficient.

DISCUSSION

Data from the present study demonstrates that age is the most outstanding factor in conscious sedation. Older subjects generally had a limited understanding of the procedure and showed less anxiety about the procedure. They were easily sedated and exhibited few signs of retching. After the procedure, they complained of little pain and did not remember the procedure compared to younger subjects. This is consistent with a previous study that reports older age is associated with greater patient satisfaction (8). Previous studies reported that midazolam elimination half-life (t1/2) is significantly prolonged in the elderly and midazolam clearance is known to be significantly higher in younger subjects (9, 10). It is also known that, under adequate surveillance, the benefits in terms of tolerance to the procedure of low dose midazolam for gastrointestinal sedation outbalance the risks in older people (11). This means that lower doses of midazolam are needed to reach sedation in older subjects. The issues of tolerance in conscious sedation appear to deal primarily with anxiety and apprehension. In our study, preprocedural anxiety level was an independent predictive factor for level of sedation and tolerance. Those subjects with high preprocedural anxiety levels complained of much more severe pain and were not easily sedated during the procedure. Females showed higher preprocedural anxiety levels as was reported in a previous study (12, 13). Concerning body mass index, slender subjects were more hyperactive and irritable during the procedure. This might be related with the fact that distribution volume (Vd) of midazolam is significantly increased in obese persons, indicating disproportionate distribution of midazolam into adipose tissue (9). Furthermore, previous experience of conscious sedation was related with lower preprocedural anxiety levels in the present study. It has been shown that individual factors such as personality, prior experience of previous procedures, and the presence of family members influence the level of anxiety and tolerance for endoscopic procedures (14-16). These studies have demonstrated that a higher pre-examination anxiety score and a previous unpleasant endoscopic experience are associated with a reduced tolerance. Although the perception of discomfort and pain may be dependent on cultural characteristics, less anxiety is related to greater patient satisfaction during conscious sedation (8, 17, 18). The limitation of the present study is that we did not use propofol which recently became popular in conscious sedation. Another limitation is that, apart from gastroscopy examination, we included those patients who underwent both gastroscopy and sigmoidoscopy examinations. These subjects were relatively more alert than those with gastroscopy examinations alone. This result might be related with increased procedural time due to sigmoidoscopy. Furthermore, it can be explained by the fact that lower intestinal endoscopy is associated with greater patient discomfort compared to upper gastroscopy (8). In conclusion, lower doses of midazolam are needed to reach sedation in the older subjects. Besides, those subjects with high preprocedural anxiety levels such as women, younger subjects, slender subjects, and those without previous experience of conscious sedation, should be observed with great caution because they generally complain of more pain and alertness during the procedure. These factors are predictive of poor tolerance and may enable the identification of the subjects who require more intense conscious sedation.
  18 in total

1.  Guidelines for the use of deep sedation and anesthesia for GI endoscopy.

Authors:  Douglas O Faigel; Todd H Baron; Jay L Goldstein; William K Hirota; Brian C Jacobson; John F Johanson; Jonathon A Leighton; J Shawn Mallery; Kathryn A Peterson; J Patrick Waring; Robert D Fanelli; Jo Wheeler-Harbaugh
Journal:  Gastrointest Endosc       Date:  2002-11       Impact factor: 9.427

2.  ASA physical status classifications: a study of consistency of ratings.

Authors:  W D Owens; J A Felts; E L Spitznagel
Journal:  Anesthesiology       Date:  1978-10       Impact factor: 7.892

3.  Does a detailed explanation prior to gastroscopy reduce the patient's anxiety?

Authors:  N Levy; L Landmann; E Stermer; M Erdreich; A Beny; R Meisels
Journal:  Endoscopy       Date:  1989-11       Impact factor: 10.093

4.  Midazolam sedation for upper gastrointestinal endoscopy: comparison between the states of patients in partial and complete amnesia.

Authors:  Tatsuaki Ishiguro; Chizuru Ishiguro; Goichi Ishiguro; Hirokazu Nagawa
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

5.  Midazolam sedation for upper gastrointestinal endoscopy in older persons: a randomized, double-blind, placebo-controlled study.

Authors:  C Christe; J P Janssens; B Armenian; F Herrmann; N Vogt
Journal:  J Am Geriatr Soc       Date:  2000-11       Impact factor: 5.562

6.  Sedation with intranasal midazolam in adults undergoing upper gastrointestinal endoscopy.

Authors:  Oya Uygur-Bayramiçli; Reşat Dabak; Tamer Kuzucuoglu; Birsel Kavakli
Journal:  J Clin Gastroenterol       Date:  2002-08       Impact factor: 3.062

7.  Conscious sedation for EUS of the esophagus and stomach: a double-blind, randomized, controlled trial comparing midazolam with placebo.

Authors:  Peter I Bonta; Maarten F Kok; Jacques J G H M Bergman; Gijs R Van den Brink; Jorrit S Lemkes; Guido N J Tytgat; Paul Fockens
Journal:  Gastrointest Endosc       Date:  2003-06       Impact factor: 9.427

8.  Pharmacokinetics of midazolam in the aged.

Authors:  M T Smith; V Heazlewood; M J Eadie; T O Brophy; J H Tyrer
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Effect of age, gender, and obesity on midazolam kinetics.

Authors:  D J Greenblatt; D R Abernethy; A Locniskar; J S Harmatz; R A Limjuco; R I Shader
Journal:  Anesthesiology       Date:  1984-07       Impact factor: 7.892

10.  Preoperative anxiety and propofol requirement in conscious sedation for ovum retrieval.

Authors:  Jeong-Yeon Hong; Inn Soo Kang; Mi Kyoung Koong; Hee Jo Yoon; Young Suck Jee; Jeong Wook Park; Mi Hyun Park
Journal:  J Korean Med Sci       Date:  2003-12       Impact factor: 2.153

View more
  10 in total

1.  Patient satisfaction after endoscopic submucosal dissection under propofol-based sedation: a small premedication makes all the difference.

Authors:  Seokyung Shin; Chan Hyuk Park; Hyun Ju Kim; Sang Hun Park; Sang Kil Lee; Young Chul Yoo
Journal:  Surg Endosc       Date:  2016-10-14       Impact factor: 4.584

2.  A survey of patients' attitudes to upper gastrointestinal endoscopy identifies the value of endoscopist-patient interactive factors.

Authors:  T Hydes; A Yusuf; D S Pearl; T M Trebble
Journal:  Frontline Gastroenterol       Date:  2011-05-04

3.  The effect of pre-procedure anxiety on sedative requirements for sedation during upper gastrointestinal endoscopy.

Authors:  Mehmet Sargın; Mehmet Uluer
Journal:  Turk J Surg       Date:  2020-12-29

4.  Usefulness of applying lidocaine in esophagogastroduodenoscopy performed under sedation with propofol.

Authors:  Felipe de la Morena; Cecilio Santander; Carlos Esteban; Beatriz de Cuenca; Juan Antonio García; Javier Sánchez; Ricardo Moreno
Journal:  World J Gastrointest Endosc       Date:  2013-05-16

5.  Randomized Controlled Study Comparing Use of Propofol Plus Fentanyl versus Midazolam Plus Fentanyl as Sedation in Diagnostic Endoscopy in Patients with Advanced Liver Disease.

Authors:  Sameh Abdelkhalik Ahmed; Amal Selim; Nehad Hawash; Ahmed Khaled Tawfik; Mohamed Yousef; Abdelrahman Kobtan; Rehab Badawi; Sally Elnawasany; Reham Abdelkader Elkhouly; Amr Shaaban Hanafy; Fatma H Rizk; Loai Mansour; Sherief Abd-Elsalam
Journal:  Int J Hepatol       Date:  2017-09-26

6.  Effects of audio and visual distraction on patients' vital signs and tolerance during esophagogastroduodenoscopy: a randomized controlled trial.

Authors:  Masahiro Sogabe; Toshiya Okahisa; Akira Fukuya; Kaizo Kagemoto; Yasuyuki Okada; Yuka Adachi; Takeshi Kurihara; Toru Nii; Satoshi Teramae; Hironori Tanaka; Tetsu Tomonari; Koichi Okamoto; Hiroshi Miyamoto; Masahiko Nakasono; Tetsuji Takayama
Journal:  BMC Gastroenterol       Date:  2020-04-21       Impact factor: 3.067

7.  Delayed flumazenil injection after endoscopic sedation increases patient satisfaction compared with immediate flumazenil injection.

Authors:  Hyun Jung Chung; Byoung Wook Bang; Hyung Gil Kim; Kye Sook Kwon; Yong Woon Shin; Seok Jeong; Don Haeng Lee; Shin Goo Park
Journal:  Gut Liver       Date:  2013-08-14       Impact factor: 4.519

8.  Anxiety Levels in Patients Undergoing Sedation for Elective Upper Gastrointestinal Endoscopy and Colonoscopy.

Authors:  Mehmet Sargin; Mehmet Selcuk Uluer; Eyüp Aydogan; Bülent Hanedan; Muhammed İsmail Tepe; Mehmet Ali Eryılmaz; Emre Ebem; Sadık Özmen
Journal:  Med Arch       Date:  2016-04-01

Review 9.  What do patients want from their endoscopy experience? The importance of measuring and understanding patient attitudes to their care.

Authors:  M Tierney; R Bevan; C J Rees; T M Trebble
Journal:  Frontline Gastroenterol       Date:  2015-06-03

10.  Premedication with benzodiazepines for upper gastrointestinal endoscopy: Comparison between oral midazolam and sublingual alprazolam.

Authors:  Vahid Sebghatollahi; Elham Tabesh; Ali Gholamrezaei; Amir Reza Zandi; Mohammad Minakari; Ahmad Shavakhi
Journal:  J Res Med Sci       Date:  2017-12-26       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.